Zobrazeno 1 - 10
of 22
pro vyhledávání: '"GA Huls"'
Autor:
MA Melo, AB Alves-Silva, NP Fonseca, I Weinhuser, ABR Bellomi, FAB Perez, LL Figueiredo-Pontes, JA Machado-Neto, L Quek, P Chatzikyriakou, GA Huls, E Ammatuna, JJ Schuringa, DA Pereira-Martins, F Traina
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 46, Iss , Pp S473-S474 (2024)
O inibidor de JAK1/2 aprovado pela FDA, Ruxolitinibe (Ruxo), é utilizado para tratar pacientes com neoplasias mieloproliferativas (NMP), oferecendo boa tolerabilidade e redução dos sintomas constitucionais. No entanto, o efeito do Ruxo na erradica
Externí odkaz:
https://doaj.org/article/cc2fa786788e4fbdb019ff4c2c34e930
Autor:
MCD Nascimento, DA Pereir-Martins, GAS Alcântara, KC Lima, HP Vicari, MJP Ferreira, LV Cost-Lotufo, GA Huls, JJ Schuringa, JA Machad-Neto, EM Rego
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 45, Iss , Pp S307- (2023)
A combinação do inibidor de BCL2 venetoclax (VEN) com agentes hipometilantes (por exemplo, azacitidina, AZA) aumentou significativamente as taxas de remissão completa (RC) e prolongou a sobrevida global de adultos com leucemia mieloide aguda (LMA)
Externí odkaz:
https://doaj.org/article/9c95817a2b17403d8b970f9964ebc980
Publikováno v:
Poster Presentations.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bb9f8e603a978c3f29a87a7128a09d1d
https://doi.org/10.1136/jitc-2022-itoc9.18
https://doi.org/10.1136/jitc-2022-itoc9.18
Autor:
Tienstra M; Department of Hematology, University of Groningen, University Medical Center, Groningen, the Netherlands., de Boer JW; Department of Hematology, University of Groningen, University Medical Center, Groningen, the Netherlands., van Doesum JA; Department of Hematology, University of Groningen, University Medical Center, Groningen, the Netherlands., Keijzer K; Department of Hematology, University of Groningen, University Medical Center, Groningen, the Netherlands., Morsink LM; Department of Hematology, University of Groningen, University Medical Center, Groningen, the Netherlands., Hazenberg CLE; Department of Hematology, University of Groningen, University Medical Center, Groningen, the Netherlands., Ammatuna E; Department of Hematology, University of Groningen, University Medical Center, Groningen, the Netherlands., Huls GA; Department of Hematology, University of Groningen, University Medical Center, Groningen, the Netherlands., Choudhary P; Diabetes Research Center, University of Leicester, Leicester, United Kingdom., Gans ROB; Department of Internal Medicine, University of Groningen, University Medical Center, Groningen, the Netherlands., Wiersma VR; Department of Hematology, University of Groningen, University Medical Center, Groningen, the Netherlands., van Meerten T; Department of Hematology, University of Groningen, University Medical Center, Groningen, the Netherlands. Electronic address: t.van.meerten@umcg.nl., van Dijk PR; Department of Endocrinology, University of Groningen, University Medical Center, Groningen, the Netherlands. Electronic address: p.r.van.dijk@umcg.nl.
Publikováno v:
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists [Endocr Pract] 2024 Sep 26. Date of Electronic Publication: 2024 Sep 26.
Autor:
Strandmoe AL; Departments of Medical Biology and Pathology.; Dermatology (Centre for Blistering Diseases)., Bremer J; Dermatology (Centre for Blistering Diseases)., Diercks GFH; Departments of Medical Biology and Pathology.; Dermatology (Centre for Blistering Diseases)., Gostyński A; Dermatology (Centre for Blistering Diseases).; Department of Dermatology, Maastricht University Medical Centre, Maastricht, the Netherlands., Ammatuna E; Haematology-Oncology., Pas HH; Dermatology (Centre for Blistering Diseases)., Wouthuyzen-Bakker M; Medical Microbiology and Infection Prevention; University of Groningen, University Medical Centre Groningen, Groningen, the Netherlands., Huls GA; Haematology-Oncology., Heeringa P; Departments of Medical Biology and Pathology., Laman JD; Departments of Medical Biology and Pathology., Horváth B; Dermatology (Centre for Blistering Diseases).
Publikováno v:
The British journal of dermatology [Br J Dermatol] 2024 Jul 16; Vol. 191 (2), pp. 164-176.
Autor:
Meeuwes FO; Department of Hematology, Treant Hospital, Emmen, The Netherlands; Department of Hematology, University Medical Center Groningen, Groningen., Brink M; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht., Plattel W; Department of Hematology, University Medical Center Groningen, Groningen., Van der Poel MWM; Department of Hematology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht., Kersten MJ; Department of Hematology, Amsterdam University Medical Centers, Cancer Center Amsterdam, Amsterdam., Wondergem M; Department of Hematology, Amsterdam University Medical Centers, Cancer Center Amsterdam, Amsterdam., Böhmer L; Department of Hematology, Haga Hospital, The Hague., Woei-A-Jin FJSH; Department of General Medical Oncology, University Hospitals Leuven, Leuven, Belgium., Visser O; Department of Hematology, Isala Hospital, Zwolle., Oostvogels R; Department of Hematology, University Medical Center Utrecht, Utrecht., Jansen PM; Department of Pathology, Leiden University Medical Center, Leiden., Neelis KJ; Department of Radiotherapy, Leiden University Medical Center, Leiden., Crijns APG; Department of Radiotherapy, University Medical Center Groningen, Groningen., Daniëls LA; Department of Radiotherapy, Amsterdam University Medical Centers, Cancer Center Amsterdam, Amsterdam., Snijders TJF; Department of Hematology, Medisch Spectrum Twente, Enschede., Vermaat JSP; Department of Hematology, Leiden University Medical Center, Leiden., Huls GA; Department of Hematology, University Medical Center Groningen, Groningen., Nijland M; Department of Hematology, University Medical Center Groningen, Groningen. m.nijland@umcg.nl.
Publikováno v:
Haematologica [Haematologica] 2024 Apr 01; Vol. 109 (4), pp. 1163-1170. Date of Electronic Publication: 2024 Apr 01.
Autor:
van de Loosdrecht AA; Department of Hematology, Amsterdam UMC, location VUmc, Cancer Center Amsterdam, Amsterdam, The Netherlands. a.vandeloosdrecht@amsterdamumc.nl., Cremers EMP; Department of Hematology, Amsterdam UMC, location VUmc, Cancer Center Amsterdam, Amsterdam, The Netherlands.; Department of Laboratory Medicine - Laboratory of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands.; Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands., Alhan C; Department of Hematology, Amsterdam UMC, location VUmc, Cancer Center Amsterdam, Amsterdam, The Netherlands., Duetz C; Department of Hematology, Amsterdam UMC, location VUmc, Cancer Center Amsterdam, Amsterdam, The Netherlands., In 't Hout FEM; Department of Laboratory Medicine - Laboratory of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands.; Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands., Visser-Wisselaar HA; HOVON Foundation, Rotterdam, The Netherlands., Chitu DA; HOVON Foundation, Rotterdam, The Netherlands.; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Verbrugge A; HOVON Foundation, Rotterdam, The Netherlands., Cunha SM; HOVON Foundation, Rotterdam, The Netherlands., Ossenkoppele GJ; Department of Hematology, Amsterdam UMC, location VUmc, Cancer Center Amsterdam, Amsterdam, The Netherlands., Janssen JJWM; Department of Hematology, Amsterdam UMC, location VUmc, Cancer Center Amsterdam, Amsterdam, The Netherlands., Klein SK; Department of Hematology, Meander Medisch Centrum, Amersfoort, The Netherlands.; Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Vellenga E; Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Huls GA; Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Muus P; Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands.; Department of Haematology, St. James University Hospital, Leeds, UK., Langemeijer SMC; Department of Laboratory Medicine - Laboratory of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands.; Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands., de Greef GE; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Te Boekhorst PAW; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Raaijmakers MHG; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., van Marwijk Kooy M; Department of Hematology, Isala Ziekenhuis, Zwolle, The Netherlands., Legdeur MC; Department of Hematology, Medisch Spectrum Twente, Enschede, The Netherlands., Wegman JJ; Department of Hematology, Deventer Ziekenhuis, Deventer, The Netherlands.; Department of Hematology, Amsterdam UMC, location AMC, Amsterdam, The Netherlands., Deenik W; Department of Internal Medicine, Tergooi Ziekenhuis, Hilversum, The Netherlands.; Department of Internal Medicine, Rijnstate, Arnhem, the Netherlands., de Weerdt O; Department of Internal Medicine, St. Antonius Ziekenhuis, Nieuwegein, The Netherlands., van Maanen-Lamme TM; Department of Internal Medicine, Dijklander Ziekenhuis, Hoorn, The Netherlands., Jobse P; Department of Internal Medicine, Admiraal de Ruyter Ziekenhuis, Goes, The Netherlands., van Kampen RJW; Department of Internal Medicine, Zuyderland Ziekenhuis, Geleen, The Netherlands., Beeker A; Department of Hematology, Spaarne Gasthuis, Hoofddorp, The Netherlands., Wijermans PW; Department of Hematology, Haaglanden Ziekenhuis, Den Haag, The Netherlands., Biemond BJ; Department of Hematology, Amsterdam UMC, location AMC, Amsterdam, The Netherlands., Tanis BC; Department of Internal Medicine, Groene Hart Ziekenhuis, Gouda, The Netherlands.; Department of General Practice Erasmus MC, Rotterdam, The Netherlands., van Esser JWJ; Department of Internal Medicine, Amphia Ziekenhuis, Breda, The Netherlands., Schaar CG; Department of Internal Medicine, Gelre Ziekenhuis, Apeldoorn, The Netherlands., Noordzij-Nooteboom HS; Department of Internal Medicine, Van Weel Bethesda Ziekenhuis, Dirksland, The Netherlands., Jacobs EMG; Department of Internal Medicine, Elkerliek Ziekenhuis, Helmond, The Netherlands., de Graaf AO; Department of Laboratory Medicine - Laboratory of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands., Jongen-Lavrencic M; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Stevens-Kroef MJPL; Department of human genetics, Radboud University Medical Center, Nijmegen, The Netherlands., Westers TM; Department of Hematology, Amsterdam UMC, location VUmc, Cancer Center Amsterdam, Amsterdam, The Netherlands., Jansen JH; Department of Laboratory Medicine - Laboratory of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands.
Publikováno v:
Leukemia [Leukemia] 2024 Apr; Vol. 38 (4), pp. 840-850. Date of Electronic Publication: 2024 Jan 31.
Autor:
Keijzer K; Department of Hematology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9713GZ, Groningen, The Netherlands.; Department of Radiation Oncology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9713GZ, Groningen, The Netherlands., de Boer JW; Department of Hematology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9713GZ, Groningen, The Netherlands., van Doesum JA; Department of Hematology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9713GZ, Groningen, The Netherlands., Noordzij W; Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9713GZ, Groningen, The Netherlands., Huls GA; Department of Hematology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9713GZ, Groningen, The Netherlands., van Dijk LV; Department of Radiation Oncology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9713GZ, Groningen, The Netherlands., van Meerten T; Department of Hematology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9713GZ, Groningen, The Netherlands., Niezink AGH; Department of Radiation Oncology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9713GZ, Groningen, The Netherlands. a.g.h.niezink@umcg.nl.
Publikováno v:
Blood cancer journal [Blood Cancer J] 2024 Mar 07; Vol. 14 (1), pp. 41. Date of Electronic Publication: 2024 Mar 07.
Autor:
Klein SK; Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Huls GA; Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Visser O; Department of Registration, Netherlands Comprehensive Cancer Organization, Utrecht, The Netherlands., Kluin-Nelemans HC; Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Dinmohamed AG; Department of Research and Development, Netherlands Comprehensive Cancer Organization, Utrecht, The Netherlands.; Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.; Department of Hematology, Amsterdam UMC, Cancer Center Amsterdam, Amsterdam, The Netherlands.
Publikováno v:
Blood advances [Blood Adv] 2023 Dec 26; Vol. 7 (24), pp. 7554-7563.
Autor:
Meeuwes FO; Department of Hematology, Treant Hospital, Emmen, the Netherlands; Department of Hematology, University Medical Center Groningen, Groningen, the Netherlands., Brink M; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, the Netherlands., van der Poel MWM; Department of Internal Medicine, Division of Hematology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, the Netherlands., Kersten MJ; Department of Hematology, Amsterdam University Medical Centers, University of Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands., Wondergem M; Department of Hematology, Amsterdam University Medical Centers, University of Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands., Mutsaers PGNJ; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Böhmer L; Department of Hematology, Haga Hospital, The Hague, the Netherlands., Woei-A-Jin S; Department of General Medical Oncology, University Hospitals Leuven, Leuven, Belgium., Visser O; Department of Hematology, Isala Hospital, Zwolle, the Netherlands., Oostvogels R; Department of Hematology, University Medical Center Utrecht, Utrecht, the Netherlands., Jansen PM; Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands., Diepstra A; Department of Pathology, University Medical Center Groningen, Groningen, the Netherlands., Snijders TJF; Department of Hematology, Medisch Spectrum Twente, Enschede, the Netherlands., Plattel WJ; Department of Hematology, University Medical Center Groningen, Groningen, the Netherlands., Huls GA; Department of Hematology, University Medical Center Groningen, Groningen, the Netherlands., Vermaat JSP; Department of Hematology, Leiden University Medical Center, Leiden, the Netherlands., Nijland M; Department of Hematology, University Medical Center Groningen, Groningen, the Netherlands. Electronic address: m.nijland@umcg.nl.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2022 Nov; Vol. 176, pp. 100-109. Date of Electronic Publication: 2022 Oct 05.